Fact CheckerSign in

NCT06281054Active, not recruiting

Acute Myocardial Infarction in Cancer Patients

Risk and Clinical Outcomes of Acute Myocardial Infarction in Patients With Cancer: A Nationwide Study

Source: ClinicalTrials.gov · Last updated 14 Mar 2025

Brief summary (registry, in English)

Using national health insurance service database, current study aim to evaluate the risk and prognosis of acute myocardial infarction in cancer patients and to find the optimal treatment strategy for acute myocardial infarction that can improve long-term prognosis.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
4500000 (estimated)
First submitted
20 Feb 2024
Start date
1 Jan 2002
Primary completion date
31 Dec 2021
Lead sponsor
Samsung Medical Center
NCT number
NCT06281054

What you commit to

  • Study type: Observational
  • Planned participants: 4500000
  • From 1 Jan 2002 to the primary completion date, 31 Dec 2021
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients who died during period of cancer diagnosis

Who the study is looking for

  • Patients diagnosed with cancer between 2002 and 2021
  • Patients who were diagnosed with acute myocardial infarction after cancer diagnosis

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Chonnam National University Hospital, Chonnam National University Medical School
Coordinator of this site? Confirm its status
GwangjuSouth KoreaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.